Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy

NCT00420303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylarthropathies, Enthesitis

Interventions

DRUG: Etanercept
OTHER: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer